1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Health benefits (QALYs) and costs for the base case scenario and subgroup analyses in symptomatic and asymptomatic patients
Imaging StrategyQALYsCost
Base case scenario:
    CTAP13.89$147,097
    TCD13.62$154,719
    Difference (CTAP-TCD)+0.27−$7,622
Symptomatic subgroup:
    CTAP13.75$149,382
    TCD13.74$152,820
    Difference (CTAP-TCD)+0.01−$3,438
Asymptomatic subgroup:
    CTAP13.99$145,228
    TCD13.51$156,272
    Difference (CTAP-TCD)+0.48−$11,044